ACTIMMUNE in Intermediate Osteopetrosis

NCT02666768 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Osteopetrosis

Interventions

DRUG: Interferon gamma-1b

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Collaborators

[object Object]
[object Object]